Patient needs have to be looked at as a global responsibility to avoid negligence or exclusion of population groups.
Clinical trials are ongoing in every country, and harmonisation across Europe through common guidelines and laboratory standards are major goals for the medical and scientific community.
A major responsibility lays in solving ethical issues for example collection, storage and retrieval of human biological samples, which should be approached in a multinational concerted effort, especially within established network structures, like the ELN.
The ELN is known for its achievements in research and therapy of leukemia:
Standardized protocols for clinical trials, important to achieve comparable data, resulting in better and equal treatment options across national borders
The development of management recommendations for all leukemias
Clinical trials on a European scale, already running in disease entities like CLL, ALL, CML and SCT (stem cell transplantation)